Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Clinical Genitourinary Cancer|February 3, 2023
Maintenance Oral Etoposide After High-Dose Chemotherapy (HDCT) for Patients With Relapsed Metastatic Germ-Cell Tumors (mGCT)Fadi Taza, Rafat Abonour, Mohammad Abu Zaid, et al.
Cancer|July 14, 2021
Survival outcomes and toxicity in patients 40 years old or older with relapsed metastatic germ cell tumors treated with high-dose chemotherapy and peripheral blood stem cell transplantationVaibhav Agrawal, Rafat Abonour, Mohammad Abu Zaid, et al.
Breast Cancer Research and Treatment|September 27, 2014
A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007Kathy D Miller, Sandra K Althouse, Lisle Nabell, et al.
Preventive Medicine|May 8, 2023
Racial disparities in cascade testing for cancer predisposition genesNawal M Kassem, Sandra K Althouse, Patrick O Monahan, et al.
Clinical Lung Cancer|August 30, 2022
A Phase II Trial of Atezolizumab Plus Carboplatin Plus Pemetrexed Plus Bevacizumab in the Treatment of Patients with Stage IV Non-Squamous Non-Small Cell Lung Cancer: Big Ten Cancer Research Consortium (BTCRC)- LUN 17-139Fatemeh Ardeshir-Larijani, Sandra K Althouse, Ticiana Leal, et al.
Cancer|May 20, 2024
High-dose chemotherapy and peripheral blood stem cell transplantation as salvage therapy in primary mediastinal nonseminomatous germ cell tumors: The Indiana University experienceNoah H Richardson, Fadi Taza, Rafat Abonour, et al.
JNCI Cancer Spectrum|March 20, 2020
Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical ManagementVaibhav Agrawal, Paul C Dinh, Chunkit Fung, et al.
Cancer|November 24, 2022
A phase 2 trial of chemotherapy plus pembrolizumab in patients with advanced non-small cell lung cancer previously treated with a PD-1 or PD-L1 inhibitor: Big Ten Cancer Research Consortium BTCRC-LUN15-029Tareq Salous, Nikhil A Shukla, Sandra K Althouse, et al.
Biomarker Research|February 20, 2022
FAM83A is a potential biomarker for breast cancer initiationNatascia Marino, Rana German, Ram Podicheti, et al.
Cell Reports. Medicine|March 25, 2021
A single-cell atlas of the healthy breast tissues reveals clinically relevant clusters of breast epithelial cellsPoornima Bhat-Nakshatri, Hongyu Gao, Liu Sheng, et al.
Pageof 4